IPP Bureau
Sun Pharma scores FDA review for ILUMYA in psoriatic arthritis
By IPP Bureau - March 18, 2026
ILUMYA has already earned FDA approvals for scalp and nail plaque psoriasis in April 2024 and December 2025
Novartis’ Cosentyx gains FDA nod for pediatric hidradenitis suppurativa patients
By IPP Bureau - March 18, 2026
The approval of Cosentyx represents an important advancement for younger HS patients who have had limited treatment options
PsiQuantum joins forces with Japan’s National Cancer Center to revolutionize cancer research with quantum computing
By IPP Bureau - March 18, 2026
The partnership will focus on advancing fault-tolerant quantum algorithms and developing clinically relevant quantum applications
Zydus, Lupin join forces to expand access to semaglutide in India
By IPP Bureau - March 18, 2026
The deal also includes upfront licensing fees and milestone-based payments from Lupin to Zydus
Lilly expands access to Zepbound weight-loss drug with $299 monthly self-pay option
By IPP Bureau - March 17, 2026
The expanded program allows patients to fill prescriptions either at a local pharmacy or through home delivery via LillyDirect
EU clears AstraZeneca’s Imfinzi combo for early gastric & GEJ cancers
By IPP Bureau - March 17, 2026
AstraZeneca says the approval strengthens its push to bring immunotherapy earlier into cancer treatment, where long-term cures are possible
Allergan Aesthetics unveils ‘Skin Quality Index’ to close gap between patients & doctors
By IPP Bureau - March 17, 2026
The framework introduces 15 consensus terms and definitions grouped across four core dimensions of skin health
Eli Lilly’s EBGLYSS shows breakthrough results in children with severe eczema
By IPP Bureau - March 17, 2026
The company announced positive topline data from the Phase 3 ADorable-1 trial
Merck doubles down on cardio-pulmonary breakthroughs
By IPP Bureau - March 17, 2026
At the center of the announcement are two late-breaking studies that could reshape treatment approaches for patients with high cholesterol and a complex form of heart failure
Samsung Biologics, Eli Lilly team up to launch major biotech hub in Korea
By IPP Bureau - March 17, 2026
The planned facility, to be built at Samsung’s Bio Campus II, is set to become a launchpad for up to 30 emerging biotech firms
BioDuro and Cenra API Solutions forge global API manufacturing joint venture in Taiwan
By IPP Bureau - March 17, 2026
The Taipei facility boasts 10 GMP API production lines, with a total reactor volume exceeding 350,000 liters
Cupid unveils “Made in India, Japanese Quality” branding to boost global presence
By IPP Bureau - March 17, 2026
The initiative comes through a collaboration with Asia’s oldest latex condom manufacturer
L&T Tech unveils AI-powered lung digital twin platform
By IPP Bureau - March 17, 2026
LTTS’ lung digital twin integrates seamlessly with CT imaging workflows, using deep learning to reconstruct a comprehensive 3D digital twin of the lungs
Johnson & Johnson reports promising early results for targeted bladder cancer therapy
By IPP Bureau - March 17, 2026
FGFR alterations are prevalent in early-stage bladder cancer, appearing in roughly 70% of intermediate-risk and 40% of high-risk NMIBC tumors
GSK expands RSV vaccine to younger adults in US, targeting high-risk 18–49 age group
By IPP Bureau - March 16, 2026
Previously, Arexvy was authorized for adults 60 and older, and for those 50–59 with heightened risk
